MR-link-2: pleiotropy robust cis Mendelian randomization validated in three independent reference datasets of causality

  • Eqtlgen Consortium
  • , Adriaan van der Graaf
  • , Robert Warmerdam
  • , Chiara Auwerx
  • , Urmo Võsa
  • , Maria-Carolina Borges
  • , Lude Franke
  • , Zoltan Kutalik

Research output: Contribution to journalArticleScientificpeer-review

5 Citations (Scopus)

Abstract

Mendelian randomization (MR) identifies causal relationships from observational data but has increased Type 1 error rates (T1E) when genetic instruments are limited to a single associated region, a typical scenario for molecular exposures. We developed MR-link-2, which leverages summary statistics and linkage disequilibrium (LD) to estimate causal effects and pleiotropy in a single region. We compare MR-link-2 to other cis MR methods: i) In simulations, MR-link-2 has calibrated T1E and high power. ii) We reidentify metabolic reactions from three metabolic pathway references using four independent metabolite quantitative trait locus studies. MR-link-2 often (76%) outperforms other methods in area under the receiver operator characteristic curve (AUC) (up to 0.80). iii) For canonical causal relationships between complex traits, MR-link-2 has lower per-locus T1E (0.096 vs. min. 0.142, at 5% level), identifying all but one of the true causal links, reducing cross-locus causal effect heterogeneity to almost half. iv) Testing causal direction between blood cell compositions and marker gene expression shows MR-link-2 has superior AUC (0.82 vs. 0.68). Finally, analyzing causality between metabolites not directly connected by canonical reactions, only MR-link-2 identifies the causal relationship between pyruvate and citrate (α̂ = 0.11, P = 7.2⋅10−7), a key citric acid cycle reaction. Overall, MR-link-2 identifies pleiotropy-robust causality from summary statistics in single associated regions, making it well suited for applications to molecular phenotypes.

Original languageEnglish
Article number6112
JournalNature Communications
Volume16
Issue number1
DOIs
Publication statusPublished - 2025
Externally publishedYes
Publication typeA1 Journal article-refereed

Funding

We would like to thank all the study participants for their altruistic donations of their biological materials. For the acknowledgments to the cohorts of the eQTLGen Consortium, we refer to the Supplementary Note. MCB’s contribution to this work was supported by the UK Medical Research Council [grant number MC_UU_00032/5]. L.F. is supported by a grant from the Dutch Research Council (ZonMW-VICI 09150182010019 to L.F.), and a sponsored research collaboration with Biogen and Roche. This work is co-financed by Oncode Institute, which is partly funded by the Dutch Cancer Society. This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101057553, a grant from Oncode Accelerator and a grant from Saxum Volutum (Pericode). Z.K. was funded by the Swiss National Science Foundation (SNSF 315230-219587).

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry,Genetics and Molecular Biology
  • General
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'MR-link-2: pleiotropy robust cis Mendelian randomization validated in three independent reference datasets of causality'. Together they form a unique fingerprint.

Cite this